Amy Pace

Amy Pace has a solid background in biostatistics and extensive experience in the pharmaceutical industry. Amy is currently working as the Vice President of Biostatistics at Parexel since May 2021. Prior to this, they held positions at Alexion Pharmaceuticals, Inc., starting as a Biostatistician in 2003 and eventually becoming the Senior Director of Biostatistics from April 2016 to May 2021. Amy also worked at Biogen, where they held several roles, including Senior Principal Biostatistician, Sr. Director of Biostatistics, and Associate Director of Medical Affairs. Amy began their career as a Research Assistant at the Board of Governors of the Federal Reserve System.

Amy Pace received a ScD in Biostatistics from Harvard T.H. Chan School of Public Health, where they studied from 1998 to 2003. Prior to that, they earned a BA in Mathematics and Economics from St. Olaf College, which they attended from 1992 to 1996.